A randomized phase III trial of palonosetron plus dexamethasone (day 1) versus palonosetron plus dexamethasone (day 1-3) in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy, not including a combination of anthracycline plus cyclophosphamide

被引：0
|
作者：
Sasaki, K. [1 ]
Okita, K. [2 ]
Yuki, S. [3 ]
Takahashi, Y. [4 ]
Abe, M. [5 ]
Hatanaka, K. [6 ]
Isobe, H. [7 ]
Sogabe, S. [8 ]
Oba, K. [9 ]
Komatsu, Y. [10 ]
机构：
[1] Otaru Ekisaikai Hosp, Otaru, Hokkaido, Japan
[2] Sapporo Med Univ Hosp, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan
[4] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[5] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan
[6] Hakodate Municipal Hosp, Hakodate, Hokkaido, Japan
[7] KKR Sapporo Med Ctr, Sapporo, Hokkaido, Japan
[8] Kushiro Rosai Hosp, Kushiro, Hokkaido, Japan
[9] Hokkaido Univ Hosp, Translat Res & Clin Trial Ctr, Sapporo, Hokkaido 060, Japan
[10] Hokkaido Univ Hosp, Ctr Canc, Sapporo, Hokkaido 060, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1303
引用
收藏
页码：S267 / S268
页数：2
相关论文
共 50 条
  • [1] Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
    Celio, Luigi
    Frustaci, Sergio
    Denaro, Angela
    Buonadonna, Angela
    Ardizzoia, Antonio
    Piazza, Elena
    Fabi, Alessandra
    Capobianco, Alba Maria
    Isa, Luciano
    Cavanna, Luigi
    Bertolini, Alessandro
    Bichisao, Ettore
    Bajetta, Emilio
    SUPPORTIVE CARE IN CANCER, 2011, 19 (08) : 1217 - 1225
  • [2] Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
    Luigi Celio
    Sergio Frustaci
    Angela Denaro
    Angela Buonadonna
    Antonio Ardizzoia
    Elena Piazza
    Alessandra Fabi
    Alba Maria Capobianco
    Luciano Isa
    Luigi Cavanna
    Alessandro Bertolini
    Ettore Bichisao
    Emilio Bajetta
    Supportive Care in Cancer, 2011, 19 : 1217 - 1225
  • [3] Palonosetron plus megestrol acetate verses palonosetron plus dexamethasone in preventing moderately emetogenic chemotherapy-induced nausea and vomiting: A randomized, multicenter, crossover, phase II trial
    Li, Q.
    Yang, B.
    Yi, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1639 - S1639
  • [4] Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy- induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial
    Cheng, Yi
    Wu, Zehua
    Shi, Lishuo
    Shen, Cailu
    Zhang, Jianwei
    Hu, Huabin
    Li, Weiwei
    Cai, Yue
    Xie, Xiaoyu
    Ling, Jiayu
    Zheng, Qin
    Deng, Yanhong
    ECLINICALMEDICINE, 2022, 49
  • [5] Exploratory study for preventing nausea and vomiting by switching from pranisetron plus dexamethasone (Days 1-3) + aprepitant (Days 1-3) to palonosetron plus pexamethasone (Day 1) in patients undergoing moderately emetogenic chemotherapy
    Kimura, T.
    Otsuka, K.
    Yaegashi, M.
    Hakozaki, M.
    Matuo, T.
    Fujii, H.
    Sato, K.
    Kamishima, M.
    Miyake, T.
    Takahara, T.
    Akiyama, Y.
    Iwaya, T.
    Nishizuka, S.
    Nitta, H.
    Koeda, K.
    Mizuno, M.
    Kimura, Y.
    Sasaki, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Effect of Palonosetron Plus 1-day Dexamethasone (DEX) on the Prevention of Delayed Nausea and Vomiting Due to Moderately Emetogenic Chemotherapy (MEC): a Pooled Analysis of Two Phase III Trials
    Celio, L.
    Bonizzoni, E.
    Bajetta, E.
    Sebastiani, S.
    Perrone, T.
    Aapro, M. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S239 - S239
  • [7] Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Longo, Flavia
    Mansueto, Giovanni
    Lapadula, Vittoria
    De Sanctis, Rita
    Quadrini, Silvia
    Grande, Roberta
    Gori, Bruno
    Altavilla, Amelia
    D'Antoni, I.
    Del Signore, Ester
    Stumbo, Luciano
    De Luca, Cristina
    Cimadon, Barbara
    Cortesi, Enrico
    Gamucci, Teresa
    Di Seri, Marisa
    SUPPORTIVE CARE IN CANCER, 2011, 19 (08) : 1159 - 1164
  • [8] Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Flavia Longo
    Giovanni Mansueto
    Vittoria Lapadula
    Rita De Sanctis
    Silvia Quadrini
    Roberta Grande
    Bruno Gori
    Amelia Altavilla
    I. D’Antoni
    Ester Del Signore
    Luciano Stumbo
    Cristina De Luca
    Barbara Cimadon
    Enrico Cortesi
    Teresa Gamucci
    Marisa Di Seri
    Supportive Care in Cancer, 2011, 19 : 1159 - 1164
  • [9] Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy
    Aapro, M.
    Fabi, A.
    Nole, F.
    Medici, M.
    Steger, G.
    Bachmann, C.
    Roncoroni, S.
    Roila, F.
    ANNALS OF ONCOLOGY, 2010, 21 (05) : 1083 - 1088
  • [10] Comparison of palonosetron (PALO) plus dexamethasone on day 1, with or without dexamethasone on days 2 and 3, in the prevention of chemotherapy induced nausea and vomiting (CINV) in breast cancer patients treated with anthracycline/cyclophosphamide regimens.
    Fabi, A.
    Nole, F.
    Roila, F.
    Medici, M.
    Steger, G.
    Bachmann, C.
    Roncoroni, S.
    Ballinari, G.
    CANCER RESEARCH, 2009, 69 (02) : 276S - 277S
12345